GROFT Stephen C.
Assisted in establishing the Office of Orphan Products Development at FDA in 1982, served as the Executive Director of the National Commission on Orphan Diseases from 1987-1989, and served as the Director of NIH’s Office of Rare Diseases Research from 1993-2014 stimulating rare diseases research and developing information for patients, families, health care providers, academic/foundation […]HETTNE Kristina
Kristina Hettne (1978), PhD, is a senior researcher at the Leiden University Medical Center in Leiden, The Netherlands. She obtained her master in computer science from Skövde University in Sweden in 2003 and shortly thereafter joined the computational toxicology group at AstraZeneca R&D in Mölndal, Sweden as a research scientist. In 2006, she moved to […]NALDINI Luigi
Luigi Naldini received his M.D. from the University of Torino, Italy in 1983 and his Ph.D. from the University of Rome in 1987, carried out post-doctoral work in the U.S.A. with Yossi Schlessinger (1987-89), was visiting scientist with Inder Verma and Didier Trono at the Salk Institute (1994-96), subsequently had independent appointments at Cell Genesys, […]SCARPA Maurizio
Director Centre for Rare Diseases Helios Dr. Horst Schmidt Kliniken GmbH Wiesbaden, Germany. Coordinator European Reference Network For Hereditary Metabolic Diseases, MetabERN Chair, ERN Coordinators Group Maurizio Scarpa, MD PhD, paediatrician, is the Director of the Centre for Rare Diseases at the Helios Dr Horst Schmidt Kliniken GmbH in Wiesbaden, Germany. He is Professor of Paediatrics at the Dept. for […]VISSERS Lisenka
Lisenka Vissers (1980), PhD, is a principal investigator at the Radboud university medical centre in Nijmegen, the Netherlands. She obtained her medical biology degree from the Radboud University Nijmegen in 2002, and obtained her PhD on molecular karyotyping by microarray-based comparative genomic hybridization in clinical care in 2007. In 2010, she was the first to […]